Surgical Science Sweden AB (publ) (STO:SUS)
Sweden flag Sweden · Delayed Price · Currency is SEK
33.26
-0.26 (-0.78%)
May 6, 2026, 5:29 PM CET

STO:SUS Revenue

In the year 2025, Surgical Science Sweden AB had annual revenue of 992.34M SEK with 12.25% growth. Surgical Science Sweden AB had revenue of 268.85M in the quarter ending December 31, 2025, with 6.88% growth.

Revenue
992.34M
Revenue Growth
+12.25%
P/S Ratio
1.72
Revenue / Employee
3.17M
Employees
313
Market Cap
1.71B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025992.34M108.26M12.25%
Dec 31, 2024884.09M1.23M0.14%
Dec 31, 2023882.85M80.31M10.01%
Dec 31, 2022802.54M435.76M118.81%
Dec 31, 2021366.78M261.98M249.98%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Getinge AB34.09B
Swedish Orphan Biovitrum AB28.96B
Sectra AB3.52B
Camurus AB2.27B
Stille AB617.41M
Saniona AB434.40M
EQL Pharma AB425.75M
Carasent AB349.05M
Revenue Rankings